Alhambra Investment Partners LLC Gilead Sciences, Inc. Transaction History

Alhambra Investment Partners LLC

  • $189 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 17, 2024
SELL
$73.27 - $83.09 $14,654 - $16,618
-200 Reduced 6.87%
2,711 $219,000
Q3 2023

Oct 17, 2023
BUY
$73.94 - $80.67 $215,239 - $234,830
2,911 New
2,911 $218,000
Q1 2023

Apr 18, 2023
SELL
$77.31 - $88.08 $14,920 - $16,999
-193 Reduced 6.96%
2,581 $214,000
Q4 2022

Jan 19, 2023
BUY
$62.32 - $89.47 $172,875 - $248,189
2,774 New
2,774 $0

Others Institutions Holding GILD

# of Institutions
1,931
Shares Held
991M
Call Options Held
10.5M
Put Options Held
9.75M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Alhambra Investment Partners LLC Portfolio

Follow Alhambra Investment Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alhambra Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alhambra Investment Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email